FDA Inspection 1082491 — Zyla Life Sciences US Inc.
The FDA completed an inspection of Zyla Life Sciences US Inc. on Feb 28, 2019 in Lake Forest, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 28, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Lake Forest, IL (United States)
Additional Details
Risk Evaluation and Mitigation Strategies (REMS)